AKEBIA THERAPEUTICS INC. Archives

Home Tags AKEBIA THERAPEUTICS INC.

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Other Events

ME Staff 8-k - May 12, 2020

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Other Events

ME Staff 8-k - April 20, 2020

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Entry into a Material...

ME Staff 8-k - April 8, 2020

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Departure of Directors or...

ME Staff 8-k - April 7, 2020

Akebia Therapeutics Inc (NASDAQ:AKBA) Insider Trading Activity – SVP Bought 27,000...

ME Staff - November 22, 2019

Akebia Therapeutics Inc (NASDAQ:AKBA) Insider Trading Activity – CEO Bought 50,000...

ME Staff - November 21, 2019

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Results of Operations and...

ME Staff 8-k - August 8, 2019

Akebia Therapeutics Inc (NASDAQ:AKBA) had its Buy ➝ Buy rating reiterated...

ME Staff - August 6, 2019

Akebia Therapeutics Inc (NASDAQ:AKBA) price target lowered to $21.00 by HC...

ME Staff - July 11, 2019

Akebia Therapeutics Inc (NASDAQ:AKBA) has coverage initiated with a Neutral rating

ME Staff - March 20, 2019

12 3 Page 1 of 3

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 12, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

October 29, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

October 15, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: AKEBIA THERAPEUTICS INC.

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Other Events

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Other Events

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Entry into a Material...

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Departure of Directors or...

Akebia Therapeutics Inc (NASDAQ:AKBA) Insider Trading Activity – SVP Bought 27,000...

Akebia Therapeutics Inc (NASDAQ:AKBA) Insider Trading Activity – CEO Bought 50,000...

AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Results of Operations and...

Akebia Therapeutics Inc (NASDAQ:AKBA) had its Buy ➝ Buy rating reiterated...

Akebia Therapeutics Inc (NASDAQ:AKBA) price target lowered to $21.00 by HC...

Akebia Therapeutics Inc (NASDAQ:AKBA) has coverage initiated with a Neutral rating

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY